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Imaging the Future of Transcatheter Aortic Valve
Replacement*
William J. Stewart, MD, FACC
Cleveland, OhioIn this issue of JACC: Cardiovascular Imaging, Moss
et al. (1) describe their experience with echocardi-
ography in 50 patients who underwent transcathe-
ter implantation of an aortic valve replacement
(TAVR) via the femoral artery. If it continues to
show reasonable safety and reliability in further
experience, this procedure may revolutionize the
field of valve replacement (2–6).
Like intraoperative echocardiography (7), ul-
trasound guidance of TAVR characterizes valve
morphology, quantitates the severity of valve
stenosis and regurgitation, and enables immedi-
ate on-line decisions to plan and define the
success of the mission. Echocardiography will
likely contribute to better outcomes of TAVR,
provided it is used optimally. But the field is new,
and there is much to learn. Echocardiographic
imaging is useful in several stages of transcatheter
valve procedures, some of which are mentioned in
the article by Moss et al. (1).
See page 15
Before TAVR, echocardiography was used to
estimate annular size, which in some patients is too
small or too large for currently available percutane-
ous devices. The aortic valve morphology is as-
sessed; bicuspid valves may or may not be less
amenable to percutaneous valve replacement. The
preoperative transthoracic echocardiography (TTE)
defines the severity of aortic stenosis and aortic
regurgitation. Both TTE and transesophageal
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Cardiovascular Imaging or the American College of Cardiology.
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trials.echocardiography (TEE) visualize the distribution
of calcium on and adjacent to the valve, the distance
from the valve to the left main coronary ostium, the
angle of the left ventricular outflow tract to the
aorta, and the baseline severity of left ventricular
size, function, and hypertrophy. In some cases,
pre-operative computerized tomography (CT) visu-
alizes some of these features, such as calcification,
better than echocardiography. Computerized to-
mography is also very useful for assessing the size of
and tortuosity of the abdominal and thoracic aorta,
and the iliac and femoral arteries used for access.
The discovery by CT or TEE of severe atheroma in
the aorta, which are likely to embolize with manipu-
lation of these large catheters, can also have an impact
on the plans for TAVR. For example, protruding
atheroma might mandate a trans apical AVR (8),
rather than a femoral procedure. Defining the size of
the sinuses of Valsalva and the sinotubular junction
may also be important if the TAVR device available is
one that anchors to the sinotubular junction (9).
During the TAVR procedure, TEE is used, more
or less constantly, to achieve numerous goals, anal-
ogous to the constant ultrasound guidance of trans-
catheter treatment of mitral stenosis (10), atrial–
septal defect (11), hypertrophic cardiomyopathy
(12), and other lesions. In the procedure room or
operating room before the intervention, the pa-
tient’s annular diameter is remeasured with TEE to
allow choice of the most appropriate AVR size. In
cases of per apical TAVR, transthoracic (TTE) and
epicardial echocardiography may be used. Trans-
thoracic echocardiography from the apical window
defines the optimum site for the incision. A sleeved
TTE probe, placed directly on the left ventricular
apical epicardium, defines the exact needle trajec-
tory and depth to reach the center of the left
ventricular cavity, which is often small and hyper-
contractile in these patients.
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26During balloon valvotomy of the stenotic aortic
alve, but before implantation of the AVR, the
ocation of the indentation on the balloon is noted
y TEE and fluoroscopy, in comparison to adjacent
andmarks. Immediately after balloon dilation,
EE rechecks the severity of aortic stenosis and
egurgitation. If acute severe regurgitation develops,
uid and vasopressor resuscitation can be made
asier by imaging left ventricular size by TEE. The
rimped AVR and stent are then positioned inside
he aortic annulus, but this crucial placement is
ifficult even when using TEE and fluoroscopic
uidance. Because of the expected 2 to 4 mm of
uperior migration during implantation (1), the start-
ng position should be with 70% of the valve inferior
o the plane of the annulus and 30% above it.
After verifying capture of rapid ventricular pacing,
he valve prosthesis is expanded within the aortic
nnulus, verified by fluoroscopy and TEE. Pacing
ust be continued until the balloon is deflated because
remature cessation of pacing may allow left ventric-
lar ejection to push the balloon-filled AVR to a more
uperior position than is desired.
Immediately after the AVR is expanded into
lace, TEE is used to assess the severity and
ocation of aortic regurgitation. Most patients have
ild perivalvular regurgitation, but if TEE shows it
o be more severe, repeat balloon dilation of the
VR can be helpful (6% in the experience of Moss
t al. [1]). The TEE imaging should assess leaflet
otion of the AVR, define dislodgement and
igration of the prosthesis, and look for impinge-
ent of the device on coronaries. The transgastric
iews are used to measure prosthetic valve gradients
nd to check for left and right ventricular dysfunc-
ion. New regional wall motion abnormalities may
e the most reliable way to detect obstruction of a
oronary orifice by the prosthesis. Other complica-
ions, such as pericardial tamponade, aortic dissec-
ion, or new mitral regurgitation, also are detectable
y echocardiography. Some vascular catastrophes,
uch as bleeding adjacent to the aorta (1), can be
iagnosed by TEE, although the sensitivity is
robably low.
After the TAVR procedure, the goals of echo-
ardiographic imaging for TAVR include follow-up
easurement of valve and ventricular function and
e-assessing the function of other valves.
For successful TAVR, high-quality imaging is
eeded. The best option seems to be a combination
f ultrasound and fluoroscopy, which are compli-
entary in guiding TAVR. Fluoroscopy and TEE
ave different strengths. Assessment of the location if wires and catheters is done better with fluoros-
opy because the echocardiographer cannot deter-
ine whether the portion of the wire or catheter
een in an imaging plane is its tip or its middle
ortion. However, TEE is more able than fluoros-
opy to assess valvular regurgitation rapidly and
epeatedly, to constantly image movement of wires
nd catheters, and to do so without radiation.
ltrasound imaging becomes more helpful in pa-
ients with less intracardiac calcium, where fluoros-
opy is less effective. Conversely, fluoroscopy be-
omes more helpful in patients who have more
alcification, because cardiac motion becomes more
pparent, whereas TEE becomes more difficult
ecause of shadowing. At the time of expansion of
he crimped bioprosthesis into its final location,
uoroscopy visualizes well the calcified native valve,
he crimped bioprosthesis, and the stent. The smart
uoroscopist uses any adjacent calcified structures as
andmarks identified during previous angiography,
ut the technique lacks depth perception. Using
chocardiography at the time of expansion of the
ioprosthesis, the crimped valve and stent are dif-
cult to see, whereas the surrounding structures
how up well. It is important for the intervention-
list, whose habit is fluoroscopy, to learn the value
f echocardiography and to marry the 2 modalities.
To function as a team, a common vocabulary is
eeded between health care professionals of differ-
nt backgrounds. Imagers, interventional cardiolo-
ists, and cardiac surgeons often use differing names
or cardiac structures, imaging planes, and direc-
ions within those planes. Communication is essen-
ial to optimally choose the proper imaging window
nd plane, visualize the area in question, and
nterpret what is shown. Manipulation of the device
hould be narrated using a common vocabulary
iscernible by all of the team.
There are numerous areas in need of further
esearch. Moss et al. (1) found an unexplained
nderestimation of annular size by TTE compared
ith TEE. Perhaps blooming of structural thick-
ess results from harmonic imaging, as mentioned,
r perhaps the annulus is not really round. This
ystematic difference might result from measuring a
ifferent plane or from foreshortening that could be
efined by computed tomographic or magnetic
esonance imaging.
We do not yet understand any predictive value in
he TEE images and whether they can forestall
rocedural complications, whether the extent or
ocation of calcification impact outcome, and what
s the response of the left ventricle and the aortic
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27eaflets to the balloon inflation and valve implanta-
ion. It is uncertain whether intracardiac imaging
13) will be of sufficient guidance to substitute for
EE. Although it would seem to be better to cross
he native valve with this large device in the very
enter of the leaflets rather than at the commissures,
t is not certain whether TEE will provide sufficient
uidance to do this. Correlations with computed
omography, magnetic resonance imaging, or
-dimensional echocardiography might allow pre-
iction of difficulty in crossing the valve or devel-
pment of a larger paravalvular leak. The shape and
ngle of the ascending aorta may be helpful in
hoosing the apical versus femoral approach to
AVR, whether the wire will easily cross the valve
r how it will lay in the commissure. Is there a role
f balloon sizing? How should periprosthetic regur-
itation be quantitated? Are there structural fea-
ures of some aortic valves, like in mitral stenosis
14), that would predict success or failure of
AVR? How do we recognize and treat immediate
ailure of TAVR (15)? All of these issues demand
urther study.
The development of TEE guidance of TAVR is
ery similar to its use in patients undergoing surgi-
al valve repair (16). In that field, the pre-pump
chocardiography provides accurate online diagno-
is of valve dysfunction, both its severity and mech-
nism. Like the post-pump intraoperative study,valve replacement in selected high- al. Percutaneous aoaneous valve interventions, and can immediately
etect complications and suboptimal results.
Some interventional cardiologists, who are
ostly accustomed to fluoroscopy alone, have ad-
ocated that TAVR can be done as well without
chocardiography guidance. This again is similar to
ntraoperative echocardiography in the early days,
efore showing that its use reduces subsequent
eoperation, for example after surgical mitral repair
17). In the article by Moss et al. (1), the Vancouver
roup is now using TEE routinely in all cases,
hereas they used it in only 74% of the first group
f patients.
Regarding percutaneous valve procedures, this
ditorial illustrates the importance of: 1) coopera-
ion between individuals from several specialties
ho partner their efforts; and 2) the role of echo-
ardiographic imaging, together with fluoroscopy,
o guide the procedural success of TAVR.
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